1. Home
  2. SILO vs MIGI Comparison

SILO vs MIGI Comparison

Compare SILO & MIGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILO
  • MIGI
  • Stock Information
  • Founded
  • SILO 2010
  • MIGI 2012
  • Country
  • SILO United States
  • MIGI United States
  • Employees
  • SILO N/A
  • MIGI N/A
  • Industry
  • SILO Apparel
  • MIGI Finance: Consumer Services
  • Sector
  • SILO Consumer Discretionary
  • MIGI Finance
  • Exchange
  • SILO Nasdaq
  • MIGI Nasdaq
  • Market Cap
  • SILO 8.0M
  • MIGI 8.7M
  • IPO Year
  • SILO N/A
  • MIGI N/A
  • Fundamental
  • Price
  • SILO $0.50
  • MIGI $1.00
  • Analyst Decision
  • SILO
  • MIGI Hold
  • Analyst Count
  • SILO 0
  • MIGI 1
  • Target Price
  • SILO N/A
  • MIGI N/A
  • AVG Volume (30 Days)
  • SILO 792.4K
  • MIGI 2.4M
  • Earning Date
  • SILO 11-12-2025
  • MIGI 11-13-2025
  • Dividend Yield
  • SILO N/A
  • MIGI N/A
  • EPS Growth
  • SILO N/A
  • MIGI N/A
  • EPS
  • SILO N/A
  • MIGI N/A
  • Revenue
  • SILO $72,102.00
  • MIGI $50,729,253.00
  • Revenue This Year
  • SILO $1.86
  • MIGI N/A
  • Revenue Next Year
  • SILO N/A
  • MIGI N/A
  • P/E Ratio
  • SILO N/A
  • MIGI N/A
  • Revenue Growth
  • SILO N/A
  • MIGI N/A
  • 52 Week Low
  • SILO $0.40
  • MIGI $0.28
  • 52 Week High
  • SILO $3.37
  • MIGI $2.33
  • Technical
  • Relative Strength Index (RSI)
  • SILO 35.63
  • MIGI 46.89
  • Support Level
  • SILO $0.50
  • MIGI $1.06
  • Resistance Level
  • SILO $0.59
  • MIGI $1.45
  • Average True Range (ATR)
  • SILO 0.05
  • MIGI 0.27
  • MACD
  • SILO -0.01
  • MIGI -0.06
  • Stochastic Oscillator
  • SILO 46.56
  • MIGI 0.00

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About MIGI Mawson Infrastructure Group Inc.

Mawson Infrastructure Group Inc is a digital infrastructure provider with diversified operations across Cryptocurrency Mining and Digital Asset Management. Its mission is to build a bridge between the rapidly emerging digital asset industry and traditional capital markets, with a focus on shareholder returns. The Company has three primary businesses: digital currency or Bitcoin self-mining, customer co-location and related services, and energy markets. It operates in a single segment surrounding its digital currency mining operation.

Share on Social Networks: